ZA200205566B - Cyclic quaternary ammonium compounds. - Google Patents

Cyclic quaternary ammonium compounds.

Info

Publication number
ZA200205566B
ZA200205566B ZA200205566A ZA200205566A ZA200205566B ZA 200205566 B ZA200205566 B ZA 200205566B ZA 200205566 A ZA200205566 A ZA 200205566A ZA 200205566 A ZA200205566 A ZA 200205566A ZA 200205566 B ZA200205566 B ZA 200205566B
Authority
ZA
South Africa
Prior art keywords
quaternary ammonium
ammonium compounds
cyclic quaternary
cyclic
compounds
Prior art date
Application number
ZA200205566A
Other languages
English (en)
Inventor
Lewis Liu Leung Choi
Clive P Page
Gregory N Beatch
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Publication of ZA200205566B publication Critical patent/ZA200205566B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA200205566A 1999-12-15 2002-07-11 Cyclic quaternary ammonium compounds. ZA200205566B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2292351 1999-12-15

Publications (1)

Publication Number Publication Date
ZA200205566B true ZA200205566B (en) 2003-11-17

Family

ID=4164887

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205566A ZA200205566B (en) 1999-12-15 2002-07-11 Cyclic quaternary ammonium compounds.

Country Status (19)

Country Link
US (1) US20030166629A1 (cs)
EP (1) EP1278731A1 (cs)
JP (1) JP2003516966A (cs)
KR (1) KR20020074170A (cs)
CN (1) CN1425005A (cs)
AU (1) AU2334501A (cs)
BG (1) BG106816A (cs)
BR (1) BR0016431A (cs)
CZ (1) CZ20022095A3 (cs)
EE (1) EE200200314A (cs)
HU (1) HUP0301686A2 (cs)
IL (1) IL150179A0 (cs)
IS (1) IS6417A (cs)
MX (1) MXPA02006051A (cs)
NO (1) NO20022870L (cs)
PL (1) PL356032A1 (cs)
WO (1) WO2001044192A1 (cs)
YU (1) YU44102A (cs)
ZA (1) ZA200205566B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063603A2 (en) 2006-11-20 2008-05-29 President And Fellows Of Harvard College Methods, compositions, and kits for treating pain and pruritis
AU2009223739A1 (en) * 2008-03-11 2009-09-17 President And Fellows Of Harvard College Methods, compositions, and kits for treating pain and pruritis
EP3485881B1 (en) * 2009-07-10 2024-03-13 President and Fellows of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
US10130632B2 (en) 2012-11-27 2018-11-20 Beth Israel Deaconess Medical Center, Inc. Methods for treating renal disease
WO2015120069A1 (en) 2014-02-04 2015-08-13 Beth Israel Deaconess Medical Center, Inc. Methods and kits for the diagnosis and treatment of pancreatic cancer
KR20180069782A (ko) 2015-08-03 2018-06-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 하전 이온 채널 블록커 및 이용 방법
AU2020237474C1 (en) 2019-03-11 2025-09-18 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN113924094A (zh) 2019-03-11 2022-01-11 诺西恩医疗公司 酯取代的离子通道阻滞剂及其使用方法
WO2020185928A1 (en) 2019-03-11 2020-09-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MX2022005335A (es) 2019-11-06 2022-08-17 Nocion Therapeutics Inc Bloqueadores de canales ionicos cargados y metodos de uso.
CA3155568A1 (en) 2019-11-06 2021-05-14 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
AU2021236130A1 (en) 2020-03-11 2022-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI58632C (fi) * 1978-02-07 1981-03-10 Orion Yhtymae Oy Foerfarande foer framstaellning av anilider med antitussiv verkan

Also Published As

Publication number Publication date
MXPA02006051A (es) 2004-08-23
WO2001044192A1 (en) 2001-06-21
IS6417A (is) 2002-06-12
CN1425005A (zh) 2003-06-18
JP2003516966A (ja) 2003-05-20
HUP0301686A2 (hu) 2003-08-28
EE200200314A (et) 2003-08-15
KR20020074170A (ko) 2002-09-28
AU2334501A (en) 2001-06-25
BR0016431A (pt) 2002-10-01
PL356032A1 (en) 2004-06-14
EP1278731A1 (en) 2003-01-29
IL150179A0 (en) 2002-12-01
NO20022870D0 (no) 2002-06-14
YU44102A (sh) 2005-09-19
BG106816A (en) 2003-04-30
US20030166629A1 (en) 2003-09-04
CZ20022095A3 (cs) 2003-02-12
NO20022870L (no) 2002-08-14

Similar Documents

Publication Publication Date Title
ZA200201269B (en) Toothbrush.
ZA200203768B (en) Toothbrush.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200108000B (en) Cosmetic compounds.
IL148291A0 (en) Aromatic nitrogen-containing 6-membered cyclic compounds
AU4114201A (en) Cyclic compounds
MXPA03004292A (es) Compuesto de lactama.
MXPA02003490A (es) Envase de carton de empaque superior.
ZA200202537B (en) Pour-on-formulations.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
ZA200108968B (en) New compounds.
ZA200205566B (en) Cyclic quaternary ammonium compounds.
ZA200110413B (en) Crystalline 1-methylcarbapenem compounds.
EG23909A (en) Vatamin d, analogs
MXPA03004250A (es) Compuesto de lactama.
MA25379A1 (fr) Composes calcilythiques.
ZA200108018B (en) Pyrrolidincarbonylamino cyclic disulfides.
ZA200200784B (en) Calcilytic compounds.
GB9925151D0 (en) Ammonium 3,5-diaminopicrate
ZA200106409B (en) Encapsulation.
ZA985239B (en) Quaternary ammonium compounds.
MXPA01007088A (es) Recuperacion de amoniaco.
ZA200108481B (en) 8A- and 9A-15-membered lactams.
AP9701074A0 (en) Quaternary ammonium compounds.
ZA200109039B (en) Brushes.